Literature DB >> 9502225

Glutamate neurotoxicity in mouse cortical neurons: atypical necrosis with DNA ladders and chromatin condensation.

S Sohn1, E Y Kim, B J Gwag.   

Abstract

The possibility that glutamate may induce neuronal apoptosis was examined in cultured cortical neurons. Neurons underwent widespread death 24 h following exposure to 50 microM glutamate. The glutamate neurotoxicity was blocked by inclusion of the glutamate antagonists, 10 microM MK-801 and 50 microM CNQX. The death was characterized by swelling cell body and bursting cytoplasmic membrane in the early phase of degeneration, suggesting that glutamate produces receptor-mediated excitotoxic necrosis. With blockade of excitotoxicity by addition of 10 microM MK-801 and 50 microM CNQX, cortical neurons exposed to 2 mM glutamate underwent necrosis morphologically identical to excitotoxicity but sensitive to 100 microM trolox, an antioxidant, suggesting that high doses of glutamate produce oxidative neuronal necrosis via non-receptor-mediated mechanisms. Interestingly, internucleosomal DNA fragmentation and chromatin condensation were observed in the course of glutamate-induced neuronal necrosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502225     DOI: 10.1016/s0304-3940(97)00936-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

Review 1.  Mitochondrial function in apoptotic neuronal cell death.

Authors:  Samantha L Budd Haeberlein
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

2.  Retinal and optic nerve evaluation by optical coherence tomography in adults with obstructive sleep apnea-hypopnea syndrome (OSAHS).

Authors:  Paula Casas; Francisco J Ascaso; Eugenio Vicente; Gloria Tejero-Garcés; María I Adiego; José A Cristóbal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-03       Impact factor: 3.117

3.  Calcium-activated NO production plays a role in neuronal death induced by beta-bungarotoxin in primary cultures of cerebellar granular neurons.

Authors:  Wen-Pei Tseng; Shoei-Yn Lin-Shiau
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-17       Impact factor: 3.000

4.  Transient NMDA receptor inactivation provides long-term protection to cultured cortical neurons from a variety of death signals.

Authors:  R Tremblay; B Chakravarthy; K Hewitt; J Tauskela; P Morley; T Atkinson; J P Durkin
Journal:  J Neurosci       Date:  2000-10-01       Impact factor: 6.167

5.  Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons.

Authors:  Ai Ying Xiao; Ling Wei; Shuli Xia; Steven Rothman; Shan Ping Yu
Journal:  J Neurosci       Date:  2002-02-15       Impact factor: 6.167

6.  Quantitative ultrasound characterization of therapy response in prostate cancer in vivo.

Authors:  Deepa Sharma; Laurentius Oscar Osapoetra; Mateusz Faltyn; Natalie Ngoc Anh Do; Anoja Giles; Martin Stanisz; Lakshmanan Sannachi; Gregory J Czarnota
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

7.  Patterns of status epilepticus-induced neuronal injury during development and long-term consequences.

Authors:  R Sankar; D H Shin; H Liu; A Mazarati; A Pereira de Vasconcelos; C G Wasterlain
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

8.  Hypoxia-ischemia and retinal ganglion cell damage.

Authors:  Charanjit Kaur; Wallace S Foulds; Eng-Ang Ling
Journal:  Clin Ophthalmol       Date:  2008-12

9.  The PSD95-nNOS interface: a target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death.

Authors:  Jiong Cao; Jenni I Viholainen; Caroline Dart; Helen K Warwick; Mark L Leyland; Michael J Courtney
Journal:  J Cell Biol       Date:  2005-01-03       Impact factor: 10.539

10.  Memantine block depends on agonist presentation at the NMDA receptor in substantia nigra pars compacta dopamine neurones.

Authors:  A R Wild; E Akyol; S L C Brothwell; P Kimkool; J N Skepper; A J Gibb; S Jones
Journal:  Neuropharmacology       Date:  2013-05-28       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.